info@marketresearchfuture.com   ๐Ÿ“ž  +1 (855) 661-4441(US)   ๐Ÿ“ž  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major playersโ€™ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Needle-Free Injection System Market Research Report Information by Product (Prefilled needle-free injectors and Fillable Needle-Free Injectors), by Type (Liquid-based needle-free injectors, Powder-Based Needle-Free Injectors, and Projectile/Depot-Based Needle-Free Injectors), by Technology (Jet-Based Needle-Free Injectors, Spring-Based Needle-Free Injectors, Microarray Patch Injectors, and Others), by Site of Delivery (Intra Dermal Injectors, Intramuscular Injectors, and Subcutaneous Injectors), by Usability (Disposable Needle-Free Inject


ID: MRFR/HC/9715-HCR | 120 Pages | Author: Kinjoll Dey| June 2024
Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

TABLE OF CONTENTS

1. REPORT PROLOGUE

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Techniques

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porterโ€™s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Impact on Supply Chain

5.3.3. Impact on Demand

5.3.4. Impact on R&D

6. GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT

6.1. Overview

6.2. Prefilled Needle-Free Injectors

Market Estimates & Forecast, by Region, 2022โ€“2030

6.3. Fillable Needle-Free Injectors

Market Estimates & Forecast, by Region, 2022โ€“2030

7. GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE

7.1. Overview

7.2. Liquid-Based Needle Free Injectors

Market Estimates & Forecast, by Region, 2022โ€“2030

7.3 Powder-Based Needle Free Injectors

Market Estimates & Forecast, by Region, 2022โ€“2030

7.1. Projectile/Depot-Based Needle Free Injectors

Market Estimates & Forecast, by Region, 2022โ€“2030

8. GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET, BY TECHNOLOGY

8.1. Overview

8.2. Jet-Based Needle-Free Injectors

Market Estimates & Forecast, by Region, 2022โ€“2030

8.3. Spring-Based Needle-Free Injectors

Market Estimates & Forecast, by Region, 2022โ€“2030

8.4. Micro Array Patch Injectors

Market Estimates & Forecast, by Region, 2022โ€“2030

8.5. Others

Market Estimates & Forecast, by Region, 2022โ€“2030

9. GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY

9.1. Overview

9.2. Intra Dermal Injectors

Market Estimates & Forecast, by Region, 2022โ€“2030

9.3. Intramuscular Injectors

Market Estimates & Forecast, by Region, 2022โ€“2030

9.4. Subcutaneous Injectors

Market Estimates & Forecast, by Region, 2022โ€“2030

10. GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY

10.1. Overview

10.2. Disposable Needle-Free Injectors

Market Estimates & Forecast, by Region, 2022โ€“2030

10.3. Reusable Needle-Free Injectors

Market Estimates & Forecast, by Region, 2022โ€“2030

11. GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION

11.1. Overview

11.2. Vaccine Delivery

Market Estimates & Forecast, by Region, 2022โ€“2030

11.3. Insulin Delivery

Market Estimates & Forecast, by Region, 2022โ€“2030

11.4. Pain Management

Market Estimates & Forecast, by Region, 2022โ€“2030

11.5. Others

Market Estimates & Forecast, by Region, 2022โ€“2030

12. GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USER

12.1. Overview

12.2. Hospitals and Clinics

Market Estimates & Forecast, by Region, 2022โ€“2030

12.3. Homecare Settings

Market Estimates & Forecast, by Region, 2022โ€“2030

12.4. Ambulatory Surgical Centers

Market Estimates & Forecast, by Region, 2022โ€“2030

12.5. Others

Market Estimates & Forecast, by Region, 2022โ€“2030

13. GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET, BY REGION

13.1. Overview

13.2. North America

13.2.1. US

13.2.2. Canada

13.3. Europe

13.3.1. Germany

13.3.2. France

13.3.3. Italy

13.3.4. Spain

13.3.5. UK

13.3.6. Rest of Europe

13.4. Asia-Pacific

13.4.1. Japan

13.4.2. China

13.4.3. India

13.4.4. Australia

13.4.5. South Korea

13.4.6. Rest of Asia-Pacific

13.5. Rest of the World

13.5.1. Middle East & Africa

13.5.2. Latin America

14. COMPANY LANDSCAPE

14.1. Overview

14.2. Competitive Analysis

14.3. Market Share Analysis

14.4. Major Growth Strategy in the Global Needle-Free Injection System Market

14.5. Competitive Benchmarking

14.6. Leading Players in Terms of Number of Developments in the Global Needle-Free Injection System Market

14.7. Key Developments and Growth Strategies

14.7.1. New Product Launch/Service Deployment

14.7.2. Merger & Acquisitions

14.7.3. Joint Ventures

14.8. Major Players Financial

14.8.1. Sales & Operating Income, 2021

14.8.2. Major Players R&D Expenditure, 2021

15. COMPANY PROFILES

15.1. Medical International Technology (MIT)

15.1.1. Company Overview

15.1.2. Products Offered

15.1.3. Financial Overview

15.1.4. Key Developments

15.1.5. SWOT Analysis

15.1.6. Key Strategies

15.2. PharmaJet.

15.2.1. Company Overview

15.2.2. Products Offered

15.2.3. Financial Overview

15.2.4. Key Developments

15.2.5. SWOT Analysis

15.2.6. Key Strategies

15.3. Antares Pharma.

15.3.1. Company Overview

15.3.2. Products Offered

15.3.3. Financial Overview

15.3.4. Key Developments

15.3.5. SWOT Analysis

15.3.6. Key Strategies

15.4. Endo International

15.4.1. Company Overview

15.4.2. Products Offered

15.4.3. Financial Overview

15.4.4. Key Developments

15.4.5. SWOT Analysis

15.4.6. Key Strategies

15.5. Ferring B.V.

15.5.1. Company Overview

15.5.2. Products Offered

15.5.3. Financial Overview

15.5.4. Key Developments

15.5.5. SWOT Analysis

15.5.6. Key Strategies

15.6. Bioject Medical Technologies

15.6.1. Company Overview

15.6.2. Products Offered

15.6.3. Financial Overview

15.6.4. Key Developments

15.6.5. SWOT Analysis

15.6.6. Key Strategies

15.7. NuGen Medical Devices

15.7.1. Company Overview

15.7.2. Products Offered

15.7.3. Financial Overview

15.7.4. Key Developments

15.7.5. SWOT Analysis

15.7.6. Key Strategies

15.8. Portal Instruments

15.8.1. Company Overview

15.8.2. Products Offered

15.8.3. Financial Overview

15.8.4. Key Developments

15.8.5. SWOT Analysis

15.8.6. Key Strategies

15.9. Enesi Pharma Limited

15.9.1. Company Overview

15.9.2. Products Offered

15.9.3. Financial Overview

15.9.4. Key Developments

15.9.5. SWOT Analysis

15.9.6. Key Strategies

15.10. Crossject

15.10.1. Company Overview

15.10.2. Products Offered

15.10.3. Financial Overview

15.10.4. Key Developments

15.10.5. SWOT Analysis

15.10.6. Key Strategies

16. APPENDIX

16.1. References

16.2. Related Reportsโ€ƒ

LIST OF TABLES

TABLE 1 GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET SYNOPSIS, 2022โ€“2030

TABLE 2 GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET ESTIMATES & FORECAST, 2022โ€“2030 (USD MILLION)

TABLE 3 GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT, 2022โ€“2030 (USD MILLION)

TABLE 4 GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE, 2022โ€“2030 (USD MILLION)

TABLE 5 GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET, BY TECHNOLOGY, 2022โ€“2030 (USD MILLION)

TABLE 6 GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY, 2022โ€“2030 (USD MILLION)

TABLE 7 GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY, 2022โ€“2030 (USD MILLION)

TABLE 8 GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION, 2022โ€“2030 (USD MILLION)

TABLE 9 GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USERS, 2022โ€“2030 (USD MILLION)

TABLE 10 NORTH AMERICA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT, 2022โ€“2030 (USD MILLION)

TABLE 11 NORTH AMERICA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE, 2022โ€“2030 (USD MILLION)

TABLE 12 NORTH AMERICA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TECHNOLOGY, 2022โ€“2030 (USD MILLION)

TABLE 13 NORTH AMERICA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY, 2022โ€“2030 (USD MILLION)

TABLE 14 NORTH AMERICA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY, 2022โ€“2030 (USD MILLION)

TABLE 15 NORTH AMERICA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION, 2022โ€“2030 (USD MILLION)

TABLE 16 NORTH AMERICA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USERS, 2022โ€“2030 (USD MILLION)

TABLE 17 US: NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT, 2022โ€“2030 (USD MILLION)

TABLE 18 US: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE, 2022โ€“2030 (USD MILLION)

TABLE 19 US: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TECHNOLOGY, 2022โ€“2030 (USD MILLION)

TABLE 20 US: NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY, 2022โ€“2030 (USD MILLION)

TABLE 21 US: NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY, 2022โ€“2030 (USD MILLION)

TABLE 22 US: NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION, 2022โ€“2030 (USD MILLION)

TABLE 23 US: NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USERS, 2022โ€“2030 (USD MILLION)

TABLE 24 CANADA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT, 2022โ€“2030 (USD MILLION)

TABLE 25 CANADA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE, 2022โ€“2030 (USD MILLION)

TABLE 26 CANADA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TECHNOLOGY, 2022โ€“2030 (USD MILLION)

TABLE 27 CANADA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY, 2022โ€“2030 (USD MILLION)

TABLE 28 CANADA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY, 2022โ€“2030 (USD MILLION)

TABLE 29 CANADA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION, 2022โ€“2030 (USD MILLION)

TABLE 30 CANADA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USERS, 2022โ€“2030 (USD MILLION)

TABLE 31 EUROPE: NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT, 2022โ€“2030 (USD MILLION)

TABLE 32 EUROPE: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE, 2022โ€“2030 (USD MILLION)

TABLE 33 EUROPE: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TECHNOLOGY, 2022โ€“2030 (USD MILLION)

TABLE 34 EUROPE: NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY, 2022โ€“2030 (USD MILLION)

TABLE 35 EUROPE: NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY, 2022โ€“2030 (USD MILLION)

TABLE 36 EUROPE: NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION, 2022โ€“2030 (USD MILLION)

TABLE 37 EUROPE: NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USERS, 2022โ€“2030 (USD MILLION)

TABLE 38 GERMANY: NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT, 2022โ€“2030 (USD MILLION)

TABLE 39 GERMANY: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE, 2022โ€“2030 (USD MILLION)

TABLE 40 GERMANY: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TECHNOLOGY, 2022โ€“2030 (USD MILLION)

TABLE 41 GERMANY: NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY, 2022โ€“2030 (USD MILLION)

TABLE 42 GERMANY: NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY, 2022โ€“2030 (USD MILLION)

TABLE 43 GERMANY: NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION, 2022โ€“2030 (USD MILLION)

TABLE 44 GERMANY: NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USERS, 2022โ€“2030 (USD MILLION)

TABLE 45 UK: NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT, 2022โ€“2030 (USD MILLION)

TABLE 46 UK: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE, 2022โ€“2030 (USD MILLION)

TABLE 47 UK: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TECHNOLOGY, 2022โ€“2030 (USD MILLION)

TABLE 48 UK: NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY, 2022โ€“2030 (USD MILLION)

TABLE 49 UK: NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY, 2022โ€“2030 (USD MILLION)

TABLE 50 UK: NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION, 2022โ€“2030 (USD MILLION)

TABLE 51 UK: NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USERS, 2022โ€“2030 (USD MILLION)

TABLE 52 FRANCE: NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT, 2022โ€“2030 (USD MILLION)

TABLE 53 FRANCE: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE, 2022โ€“2030 (USD MILLION)

TABLE 54 FRANCE: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TECHNOLOGY, 2022โ€“2030 (USD MILLION)

TABLE 55 FRANCE: NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY, 2022โ€“2030 (USD MILLION)

TABLE 56 FRANCE: NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY, 2022โ€“2030 (USD MILLION)

TABLE 57 FRANCE: NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION, 2022โ€“2030 (USD MILLION)

TABLE 58 FRANCE: NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USERS, 2022โ€“2030 (USD MILLION)

TABLE 59 ITALY: NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT, 2022โ€“2030 (USD MILLION)

TABLE 60 ITALY: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE, 2022โ€“2030 (USD MILLION)

TABLE 61 ITALY: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TECHNOLOGY, 2022โ€“2030 (USD MILLION)

TABLE 62 ITALY: NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY, 2022โ€“2030 (USD MILLION)

TABLE 63 ITALY: NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY, 2022โ€“2030 (USD MILLION)

TABLE 64 ITALY: NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION, 2022โ€“2030 (USD MILLION)

TABLE 65 ITALY: NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USERS, 2022โ€“2030 (USD MILLION)

TABLE 66 SPAIN: NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT, 2022โ€“2030 (USD MILLION)

TABLE 67 SPAIN: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE, 2022โ€“2030 (USD MILLION)

TABLE 68 SPAIN: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TECHNOLOGY, 2022โ€“2030 (USD MILLION)

TABLE 69 SPAIN: NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY, 2022โ€“2030 (USD MILLION)

TABLE 70 SPAIN: NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY, 2022โ€“2030 (USD MILLION)

TABLE 71 SPAIN: NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION, 2022โ€“2030 (USD MILLION)

TABLE 72 SPAIN: NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USERS, 2022โ€“2030 (USD MILLION)

TABLE 73 REST OF EUROPE: NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT, 2022โ€“2030 (USD MILLION)

TABLE 74 REST OF EUROPE: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE, 2022โ€“2030 (USD MILLION)

TABLE 75 REST OF EUROPE: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TECHNOLOGY, 2022โ€“2030 (USD MILLION)

TABLE 76 REST OF EUROPE: NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY, 2022โ€“2030 (USD MILLION)

TABLE 77 REST OF EUROPE: NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY, 2022โ€“2030 (USD MILLION)

TABLE 78 REST OF EUROPE: NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION, 2022โ€“2030 (USD MILLION)

TABLE 79 REST OF EUROPE: NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USERS, 2022โ€“2030 (USD MILLION)

TABLE 80 ASIA-PACIFIC: NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT, 2022โ€“2030 (USD MILLION)

TABLE 81 ASIA-PACIFIC: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE, 2022โ€“2030 (USD MILLION)

TABLE 82 ASIA-PACIFIC: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TECHNOLOGY, 2022โ€“2030 (USD MILLION)

TABLE 83 ASIA-PACIFIC: NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY, 2022โ€“2030 (USD MILLION)

TABLE 84 ASIA-PACIFIC: NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY, 2022โ€“2030 (USD MILLION)

TABLE 85 ASIA-PACIFIC: NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION, 2022โ€“2030 (USD MILLION)

TABLE 86 ASIA-PACIFIC: NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USERS, 2022โ€“2030 (USD MILLION)

TABLE 87 INDIA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT, 2022โ€“2030 (USD MILLION)

TABLE 88 INDIA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE, 2022โ€“2030 (USD MILLION)

TABLE 89 INDIA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TECHNOLOGY, 2022โ€“2030 (USD MILLION)

TABLE 90 INDIA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY, 2022โ€“2030 (USD MILLION)

TABLE 91 INDIA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY, 2022โ€“2030 (USD MILLION)

TABLE 92 INDIA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION, 2022โ€“2030 (USD MILLION)

TABLE 93 INDIA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USERS, 2022โ€“2030 (USD MILLION)

TABLE 94 CHINA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT, 2022โ€“2030 (USD MILLION)

TABLE 95 CHINA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE, 2022โ€“2030 (USD MILLION)

TABLE 96 CHINA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TECHNOLOGY, 2022โ€“2030 (USD MILLION)

TABLE 97 CHINA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY, 2022โ€“2030 (USD MILLION)

TABLE 98 CHINA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY, 2022โ€“2030 (USD MILLION)

TABLE 99 CHINA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION, 2022โ€“2030 (USD MILLION)

TABLE 100 CHINA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USERS, 2022โ€“2030 (USD MILLION)

TABLE 101 JAPAN: NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT, 2022โ€“2030 (USD MILLION)

TABLE 102 JAPAN: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE, 2022โ€“2030 (USD MILLION)

TABLE 103 JAPAN: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TECHNOLOGY, 2022โ€“2030 (USD MILLION)

TABLE 104 JAPAN: NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY, 2022โ€“2030 (USD MILLION)

TABLE 105 JAPAN: NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY, 2022โ€“2030 (USD MILLION)

TABLE 106 JAPAN: NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION, 2022โ€“2030 (USD MILLION)

TABLE 107 JAPAN: NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USERS, 2022โ€“2030 (USD MILLION)

TABLE 108 AUSTRALIA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT, 2022โ€“2030 (USD MILLION)

TABLE 109 AUSTRALIA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE, 2022โ€“2030 (USD MILLION)

TABLE 110 AUSTRALIA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TECHNOLOGY, 2022โ€“2030 (USD MILLION)

TABLE 111 AUSTRALIA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY, 2022โ€“2030 (USD MILLION)

TABLE 112 AUSTRALIA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY, 2022โ€“2030 (USD MILLION)

TABLE 113 AUSTRALIA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION, 2022โ€“2030 (USD MILLION)

TABLE 114 AUSTRALIA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USERS, 2022โ€“2030 (USD MILLION)

TABLE 115 SOUTH KOREA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT, 2022โ€“2030 (USD MILLION)

TABLE 116 SOUTH KOREA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE, 2022โ€“2030 (USD MILLION)

TABLE 117 SOUTH KOREA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TECHNOLOGY, 2022โ€“2030 (USD MILLION)

TABLE 118 SOUTH KOREA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY, 2022โ€“2030 (USD MILLION)

TABLE 119 SOUTH KOREA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY, 2022โ€“2030 (USD MILLION)

TABLE 120 SOUTH KOREA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION, 2022โ€“2030 (USD MILLION)

TABLE 121 SOUTH KOREA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USERS, 2022โ€“2030 (USD MILLION)

TABLE 122 REST OF ASIA-PACIFIC: NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT, 2022โ€“2030 (USD MILLION)

TABLE 123 REST OF ASIA-PACIFIC: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE, 2022โ€“2030 (USD MILLION)

TABLE 124 REST OF ASIA-PACIFIC: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TECHNOLOGY, 2022โ€“2030 (USD MILLION)

TABLE 125 REST OF ASIA-PACIFIC: NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY, 2022โ€“2030 (USD MILLION)

TABLE 126 REST OF ASIA-PACIFIC: NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY, 2022โ€“2030 (USD MILLION)

TABLE 127 REST OF ASIA-PACIFIC: NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION, 2022โ€“2030 (USD MILLION)

TABLE 128 REST OF ASIA-PACIFIC: NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USERS, 2022โ€“2030 (USD MILLION)

TABLE 129 REST OF THE WORLD: NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT, 2022โ€“2030 (USD MILLION)

TABLE 130 REST OF THE WORLD: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE, 2022โ€“2030 (USD MILLION)

TABLE 131 REST OF THE WORLD: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TECHNOLOGY, 2022โ€“2030 (USD MILLION)

TABLE 132 REST OF THE WORLD: NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY, 2022โ€“2030 (USD MILLION)

TABLE 133 REST OF THE WORLD: NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY, 2022โ€“2030 (USD MILLION)

TABLE 134 REST OF THE WORLD: NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION, 2022โ€“2030 (USD MILLION)

TABLE 135 REST OF THE WORLD: NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USERS, 2022โ€“2030 (USD MILLION)

TABLE 136 MIDDLE EAST: NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT, 2022โ€“2030 (USD MILLION)

TABLE 137 MIDDLE EAST: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE, 2022โ€“2030 (USD MILLION)

TABLE 138 MIDDLE EAST: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TECHNOLOGY, 2022โ€“2030 (USD MILLION)

TABLE 139 MIDDLE EAST: NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY, 2022โ€“2030 (USD MILLION)

TABLE 140 MIDDLE EAST: NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY, 2022โ€“2030 (USD MILLION)

TABLE 141 MIDDLE EAST: NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION, 2022โ€“2030 (USD MILLION)

TABLE 142 MIDDLE EAST: NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USERS, 2022โ€“2030 (USD MILLION)

TABLE 143 AFRICA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT, 2022โ€“2030 (USD MILLION)

TABLE 144 AFRICA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE, 2022โ€“2030 (USD MILLION)

TABLE 145 AFRICA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TECHNOLOGY, 2022โ€“2030 (USD MILLION)

TABLE 146 AFRICA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY, 2022โ€“2030 (USD MILLION)

TABLE 147 AFRICA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY USABILITY, 2022โ€“2030 (USD MILLION)

TABLE 148 AFRICA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION, 2022โ€“2030 (USD MILLION)

TABLE 149 AFRICA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USERS, 2022โ€“2030 (USD MILLION)

TABLE 150 LATIN AMERICA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY PRODUCT, 2022โ€“2030 (USD MILLION)

TABLE 151 LATIN AMERICA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TYPE, 2022โ€“2030 (USD MILLION)

TABLE 152 LATIN AMERICA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY TECHNOLOGY, 2022โ€“2030 (USD MILLION)

TABLE 153 LATIN AMERICA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY SITE OF DELIVERY, 2022โ€“2030 (USD MILLION)

TABLE 154 LATIN AMERICA: NEEDLE-FREE INJECTION SYSTEM MARKET, USABILITY, 2022โ€“2030 (USD MILLION)

TABLE 155 LATIN AMERICA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY APPLICATION, 2022โ€“2030 (USD MILLION)

TABLE 156 LATIN AMERICA: NEEDLE-FREE INJECTION SYSTEM MARKET, BY END USERS, 2022โ€“2030 (USD MILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET

FIGURE 4 GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET SHARE (%), BY PRODUCT, 2021

FIGURE 5 GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET SHARE (%), BY TYPE, 2021

FIGURE 6 GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET SHARE (%), BY TECHNOLOGY, 2021

FIGURE 7 GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET SHARE (%), BY SITE OF DELIVERY, 2021

FIGURE 8 GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET SHARE (%), BY USABILITY, 2021

FIGURE 9 GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET SHARE (%), BY APPLICATION, 2021

FIGURE 10 GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET SHARE (%), BY END USERS, 2021

FIGURE 11 GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET SHARE (%), BY REGION, 2021

FIGURE 12 NORTH AMERICA: NEEDLE-FREE INJECTION SYSTEM MARKET SHARE (%), BY REGION, 2021 (%)

FIGURE 13 EUROPE: NEEDLE-FREE INJECTION SYSTEM MARKET SHARE (%), BY REGION, 2021

FIGURE 14 ASIA-PACIFIC: NEEDLE-FREE INJECTION SYSTEM MARKET SHARE (%), BY REGION, 2021

FIGURE 15 REST OF THE WORLD: NEEDLE-FREE INJECTION SYSTEM MARKET SHARE, BY REGION, 2021 (%)

FIGURE 16 GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET: COMPANY SHARE(%) ANALYSIS, 2021 (%)

FIGURE 17 MEDICAL INTERNATIONAL TECHNOLOGY (MIT): KEY FINANCIAL OVERVIEW SNAPSHOT

FIGURE 18 MEDICAL INTERNATIONAL TECHNOLOGY (MIT): SWOT ANALYSIS

FIGURE 19 PHARMAJET.: KEY FINANCIAL OVERVIEW SNAPSHOT

FIGURE 20 PHARMAJET.: SWOT ANALYSIS

FIGURE 21 THERMO FISHER SCIENTIFIC, INC.: KEY FINANCIAL OVERVIEW SNAPSHOT

FIGURE 22 THERMO FISHER SCIENTIFIC, INC.: SWOT ANALYSIS

FIGURE 23 ENDO INTERNATIONAL.: KEY FINANCIAL OVERVIEW SNAPSHOT

FIGURE 24 ENDO INTERNATIONAL.: SWOT ANALYSIS

FIGURE 25 FERRING B.V.: KEY FINANCIAL OVERVIEW SNAPSHOT

FIGURE 26 FERRING B.V.: SWOT ANALYSIS

FIGURE 27 BIOJECT MEDICAL TECHNOLOGIES: KEY FINANCIAL OVERVIEW SNAPSHOT

FIGURE 28 BIOJECT MEDICAL TECHNOLOGIES: SWOT ANALYSIS

FIGURE 29 NUGEN MEDICAL DEVICES: KEY FINANCIAL OVERVIEW SNAPSHOT

FIGURE 30 NUGEN MEDICAL DEVICES: SWOT ANALYSIS

FIGURE 31 PORTAL INSTRUMENTS: KEY FINANCIAL OVERVIEW SNAPSHOT

FIGURE 32 PORTAL INSTRUMENTS: KEY SWOT ANALYSIS

FIGURE 33 ENESI PHARMA LIMITED: KEY FINANCIAL OVERVIEW SNAPSHOT

FIGURE 34 ENESI PHARMA LIMITED: SWOT ANALYSIS

FIGURE 35 CROSSJECT: KEY FINANCIAL OVERVIEW SNAPSHOT

FIGURE 36 CROSSJECT: SWOT ANALYSIS

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.